Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6312358rdf:typepubmed:Citationlld:pubmed
pubmed-article:6312358lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:6312358lifeskim:mentionsumls-concept:C0027358lld:lifeskim
pubmed-article:6312358lifeskim:mentionsumls-concept:C0034801lld:lifeskim
pubmed-article:6312358lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:6312358lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:6312358pubmed:issue8lld:pubmed
pubmed-article:6312358pubmed:dateCreated1983-11-23lld:pubmed
pubmed-article:6312358pubmed:abstractTextIn vivo binding assay of opioid receptors for naloxone was tested in morphine-dependent mice. The content of naloxone in the brain (whole brain minus cerebellum) and cerebellum was determined as the total binding and non-specific binding, respectively, 20 min after the intravenous injection of [3H]-naloxone. Acute treatment with 8 mg/kg of morphine sulfate markedly enhanced the non-specific binding of naloxone. In contrast, withdrawal for 6 hr after 72 hr of implantation of morphine decreased the non-specific binding of naloxone. The Scatchard analysis of the specific binding revealed two binding sites. The apparent low affinity Kd values of both morphine-tolerant and morphine-withdrawn mice were significantly decreased when compared to their respective controls. The apparent high affinity Kd and the high and low Bmax values were not altered by the morphine dependent-tolerant state.lld:pubmed
pubmed-article:6312358pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6312358pubmed:languageenglld:pubmed
pubmed-article:6312358pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6312358pubmed:citationSubsetIMlld:pubmed
pubmed-article:6312358pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6312358pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6312358pubmed:statusMEDLINElld:pubmed
pubmed-article:6312358pubmed:monthAuglld:pubmed
pubmed-article:6312358pubmed:issn0028-3908lld:pubmed
pubmed-article:6312358pubmed:authorpubmed-author:TakemoriA EAElld:pubmed
pubmed-article:6312358pubmed:authorpubmed-author:OzakiMMlld:pubmed
pubmed-article:6312358pubmed:authorpubmed-author:OishiRRlld:pubmed
pubmed-article:6312358pubmed:issnTypePrintlld:pubmed
pubmed-article:6312358pubmed:volume22lld:pubmed
pubmed-article:6312358pubmed:ownerNLMlld:pubmed
pubmed-article:6312358pubmed:authorsCompleteYlld:pubmed
pubmed-article:6312358pubmed:pagination1015-9lld:pubmed
pubmed-article:6312358pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:6312358pubmed:meshHeadingpubmed-meshheading:6312358-...lld:pubmed
pubmed-article:6312358pubmed:meshHeadingpubmed-meshheading:6312358-...lld:pubmed
pubmed-article:6312358pubmed:meshHeadingpubmed-meshheading:6312358-...lld:pubmed
pubmed-article:6312358pubmed:meshHeadingpubmed-meshheading:6312358-...lld:pubmed
pubmed-article:6312358pubmed:meshHeadingpubmed-meshheading:6312358-...lld:pubmed
pubmed-article:6312358pubmed:meshHeadingpubmed-meshheading:6312358-...lld:pubmed
pubmed-article:6312358pubmed:meshHeadingpubmed-meshheading:6312358-...lld:pubmed
pubmed-article:6312358pubmed:meshHeadingpubmed-meshheading:6312358-...lld:pubmed
pubmed-article:6312358pubmed:meshHeadingpubmed-meshheading:6312358-...lld:pubmed
pubmed-article:6312358pubmed:meshHeadingpubmed-meshheading:6312358-...lld:pubmed
pubmed-article:6312358pubmed:meshHeadingpubmed-meshheading:6312358-...lld:pubmed
pubmed-article:6312358pubmed:year1983lld:pubmed
pubmed-article:6312358pubmed:articleTitleIn vivo binding of naloxone to opioid receptors in morphine-dependent mice.lld:pubmed
pubmed-article:6312358pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6312358pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed